Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Olostar vs Olmetec and Crestor in Healthy Volunteers
NCT02561884Phase 1Unknown
- Sponsor
- Daewoong Pharmaceutical
- Start
- Oct 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of olmesartan medoxomil + amlodipine in hypertension (HTN) and dyslipidemia (2 arms), sponsored by Daewoong Pharmaceutical. Primary endpoints: Area Under the Curve and Maximum Concentration. Status: unknown.
02
Drugs
olmesartan medoxomil + amlodipine
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT02561884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02561884.